Our micro-elimination projects are helping to fuel new models of care from the prisons of Portugal to the remote mountains of South Korea. These selected efforts are a preview of AbbVie projects being conducted around the world aimed at helping eliminate hepatitis C (HCV)—with more to come:

AbbVie Estonia

From Micro to Macro

In Estonia, a protocol is being developed to test, treat and follow up with adult hospital patients with elevated liver enzymes who are at risk for hepatitis C infection. Today, these patients are undiagnosed due to the lack of funding for screening.

AbbVie Germany

Project Plus

In Germany, a new referral network called Project Plus has been set up at addiction treatment centers. The network is helping people who inject drugs battle addiction, along with the other challenges they face, enabling them to prioritize seeking hepatitis C care.

AbbVie Portugal

One Step More

In Portugal, a former inmate has created a peer-to-peer counseling program, One Step More, that goes inside prison walls to motivate people to seek hepatitis C care.

AbbVie Russia

HCV Free Childhood

A new project in Russia is developing a roadmap to maximize adolescent screening for hepatitis C as well as creating a patient registry to improve referral.

AbbVie Spain

Hospital Clinic of Barcelona

A project in Spain is helping to facilitate hepatitis C patient referrals from general practitioners to specialists, and build a referral network at harm reduction centers to help people who inject drugs.

AbbVie South Korea

HCV Free Gurye

In a remote South Korean mountain town, physicians and medical education experts are raising awareness of hepatitis C and helping to screen and test adults aged 40-79, a high-risk age group.

The World Health Organization's 2030 goal to eliminate hepatitis C is only 9 years away. We all have a part to play. Learn more about how we’re moving fast and working hard to help eliminate hepatitis C.

AbbVie SA/NV - BE-ABBV-210067 (v1.0) - August 2021